Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.44%
1,101.49
-4.87
-0.44%
—1,106.361,105.681,109.291,098.92——
SIXC
Communications
SIXC
Communications
SIXC
+0.48%
613.21
+2.92
+0.48%
—610.29610.29614.07610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.44%
1,216.52
+5.30
+0.44%
—1,211.221,211.011,220.571,209.79——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.05%
1,751.56
+0.85
+0.05%
—1,750.711,753.101,762.131,749.56——
SIXM
Financials
SIXM
Financials
SIXM
+0.51%
631.35
+3.18
+0.51%
—628.17629.38633.75629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.48%
858.65
+4.08
+0.48%
—854.57855.71858.96855.71——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.17%
217.24
+0.37
+0.17%
—216.87216.87217.75216.17——
SIXT
Technology
SIXT
Technology
SIXT
+0.59%
3,583.01
+21.07
+0.59%
—3,561.943,571.443,600.643,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.20%
905.12
+1.81
+0.20%
—903.31903.26906.56901.88——
SIXV
Health care
SIXV
Health care
SIXV
+0.34%
1,486.57
+5.03
+0.34%
—1,481.541,482.481,486.761,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.28%
2,406.65
+6.70
+0.28%
—2,399.952,404.452,412.722,404.45——
ECL:NYSE
Ecolab Inc
$249.29
-0.13%
(-0.66) 1D
May 14, 10:15:48 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECL...
Open
$250.00
High
$251.07
Low
$248.86
Mkt. cap
70.40B
Avg. vol.
1.40M
Volume
127.87K
Dividend
1.17%
Quarterly dividend
$0.73
Ex dividend date
Mar 17, 2026
P/E ratio
33.69
52-wk high
$309.27
52-wk low
$248.60
EPS
$7.39
Beta
0.92
Shares outstanding
281.44M
No. of employees
48K
News stories
From sources across the web
Profile
Ecolab Inc., headquartered in Saint Paul, Minnesota, provides products related to water treatment, sanitation, and hygiene, primarily to commercial and industrial customers. The company is ranked 274th on the Fortune 500 and 569th on the Forbes Global 2000. Wikipedia
About Ecolab Inc
CEOChristophe Beck
Employees48K
Founded1923
HeadquartersSaint Paul, Minnesota, United States
SectorSpeciality chemicals
Websiteecolab.com
Last report
Apr 28, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$1.70 / $1.70
+0.16%beat
Revenue / Est. (USD)
4.07B / 4.01B
+1.28%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.03B
4.16B
4.20B
4.07B
Cost of goods sold
2.22B
2.30B
2.35B
2.28B
Cost of revenue
2.22B
2.30B
2.35B
2.28B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.05B
1.07B
1.05B
1.09B
Operating expense
1.05B
1.07B
1.05B
1.09B
Total operating expenses
3.28B
3.37B
3.40B
3.38B
Operating income
750.20M
799.50M
799.30M
688.50M
Other non operating income
-
-
-
-
EBT including unusual items
659.90M
717.70M
660.30M
558.10M
EBT excluding unusual items
687.00M
744.20M
735.00M
615.80M
Income tax expense
131.40M
128.00M
91.70M
121.50M
Effective tax rate
19.91%
17.83%
13.89%
21.77%
Other operating expenses
-
-
-
-
Net income
524.20M
585.00M
563.90M
432.60M
Net profit margin
13.02%
14.05%
13.44%
10.64%
Earnings per share
1.89
2.07
2.08
1.70
Interest and investment income
13.00M
19.30M
18.60M
4.60M
Interest expense
-76.20M
-74.60M
-82.90M
-77.30M
Net interest expenses
-63.20M
-55.30M
-64.30M
-72.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
991.90M
1.04B
1.06B
951.60M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer